ÜBER DIESE EPISODE
Veeva's Florian Schnappauf speaks to Andy Eeckhout of ADVANZ PHARMA about ensuring launch success. Preparing for a launch is a high-stakes gamble for all biopharma companies, particularly those focused on rare diseases. Andy explains how ADVANZ uses data to prepare for a launch, scale across multiple markets, and help MSLs get up-to-speed quickly for an in-depth scientific discussion with experts.
Englisch
Vereinigte Staaten
TRANSKRIPT 🔗
1
00:00:00,208 --> 00:00:03,375
(bright upbeat music)
2
00:00:08,640 --> 00:00:10,620
- Hello everyone, and thank you very much
3
00:00:10,620 --> 00:00:13,443
for joining today's podcast episode.
4
00:00:14,340 --> 00:00:15,990
We have an exciting topic today.
5
00:00:15,990 --> 00:00:19,260
We're going to be talking
about launch in commercial
6
00:00:19,260 --> 00:00:21,270
and specifically in rare diseases,
7
00:00:21,270 --> 00:00:24,360
and I'm very, very
pleased to be joined today
8
00:00:…
00:00:00,208 --> 00:00:03,375
(bright upbeat music)
2
00:00:08,640 --> 00:00:10,620
- Hello everyone, and thank you very much
3
00:00:10,620 --> 00:00:13,443
for joining today's podcast episode.
4
00:00:14,340 --> 00:00:15,990
We have an exciting topic today.
5
00:00:15,990 --> 00:00:19,260
We're going to be talking
about launch in commercial
6
00:00:19,260 --> 00:00:21,270
and specifically in rare diseases,
7
00:00:21,270 --> 00:00:24,360
and I'm very, very
pleased to be joined today
8
00:00:…
VERGANGENE FOLGEN SUCHEN
Vorhandene Folgen von What Pharma Needs Next durchsuchen.
Rechtliche Hinweise: Der auf dieser Seite eingebettete Podcast und das Bildmaterial stammen von Veeva Systems, das Eigentum seines Eigentümers ist und nicht mit Listen Notes, Inc. verbunden ist oder von diesen unterstützt wird.
BEARBEITEN
Vielen Dank, dass Sie uns helfen, die Podcast-Datenbank auf dem neuesten Stand zu halten.